WAM
RPTP

Wolverine Asset Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Wolverine Asset Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,400
Closed -$84K – 1475
2016
Q3 		$84K Buy
+9,400
New +$66.8K ﹤0.01% 995

Wolverine Asset Management's RPTP Position: Q4 2016 in Review

Wolverine Asset Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 9,400 shares — an estimated $84K sold.

Wolverine Asset Management first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $84K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Wolverine Asset Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Wolverine Asset Management sold 9,400 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $84K.
  • Wolverine Asset Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Wolverine Asset Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $84K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.